Clues from hypercalcaemia
2002
Clues from hypercalcaemia
Editorial
Author Information
Author(s): Nicholson S, Waxman J
Primary Institution: Department of Cancer Medicine, Faculty of Medicine, Imperial College of Science, Technology & Medicine
Conclusion
PTHrP may play a significant role in the progression of malignant diseases, particularly in breast and prostate cancers.
Supporting Evidence
- PTHrP is present in around 80% of patients with humoral hypercalcaemia.
- Studies show that PTHrP is expressed in most breast cancer primaries and bony metastases.
- Animal experiments indicate the importance of PTHrP in progression to metastatic bone disease.
Takeaway
This study talks about a protein called PTHrP that can affect how cancer spreads in the body, especially in bones.
Limitations
The sample sizes in the studies discussed are small, requiring larger studies for conclusive results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website